AP2009004891A0 - New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number: AP2009004891A0
Authority: AP; ARIPO
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; azabicyclic compounds; new
Prior art date: 2008-06-13

Application number

AP2009004891A

Other languages

English (en)

Inventor

Anita Roger

Anne-Marie Chollet

Alain Dhainaut

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-06-13

Filing date

2009-06-08

Publication date

2009-06-30

2009-06-08 Application filed by Servier Lab filed Critical Servier Lab

2009-06-30 Publication of AP2009004891A0 publication Critical patent/AP2009004891A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Psychology (AREA)
Epidemiology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AP2009004891A 2008-06-13 2009-06-08 New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them AP2009004891A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0803297A FR2932479A1 (fr)	2008-06-13	2008-06-13	Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number	Publication Date
AP2009004891A0 true AP2009004891A0 (en)	2009-06-30

Family

ID=40227963

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2009004891A AP2009004891A0 (en)	2008-06-13	2009-06-08	New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (29)

Country	Link
US (1)	US7906547B2 (es)
EP (1)	EP2133333A1 (es)
JP (1)	JP2009298790A (es)
KR (1)	KR20090129958A (es)
CN (1)	CN101602706A (es)
AP (1)	AP2009004891A0 (es)
AR (1)	AR072101A1 (es)
AU (1)	AU2009202341A1 (es)
BR (1)	BRPI0902395A2 (es)
CA (1)	CA2668527A1 (es)
CL (1)	CL2009001377A1 (es)
CO (1)	CO6190096A1 (es)
CR (1)	CR10844A (es)
EA (1)	EA200900692A1 (es)
EC (1)	ECSP099396A (es)
FR (1)	FR2932479A1 (es)
GT (1)	GT200900150A (es)
MA (1)	MA31141B1 (es)
MX (1)	MX2009005891A (es)
MY (1)	MY144748A (es)
NI (1)	NI200900114A (es)
NZ (1)	NZ577438A (es)
PE (1)	PE20091961A1 (es)
SG (1)	SG158015A1 (es)
SV (1)	SV2009003292A (es)
TW (1)	TW201000101A (es)
UY (1)	UY31857A1 (es)
WO (1)	WO2009150331A1 (es)
ZA (1)	ZA200903939B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10892398B2 (en) *	2019-03-28	2021-01-12	Johannes Pollanen	Qubit hardware for electrons on helium
EP4251148A1 (en)	2020-11-27	2023-10-04	Richter Gedeon Nyrt.	Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6515013B2 (en) *	2000-07-13	2003-02-04	Abbott Laboratories	1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
US7232835B2 (en) *	2002-12-10	2007-06-19	Ranbaxy Laboratories Limited	3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists
FR2866647B1 (fr) *	2004-02-20	2006-10-27	Servier Lab	Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1707203A1 (en) *	2005-04-01	2006-10-04	Bioprojet	Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3- receptor ligands
AU2006231917B2 (en) *	2005-04-08	2011-07-28	Pfizer Products Inc.	Bicyclic [3.1.0] heteroaryl amides as type I glycine transport inhibitors
EP1842846A1 (en) *	2006-04-07	2007-10-10	Santhera Pharmaceuticals (Schweiz) AG	Phenylpiperidine derivatives as melanocortin-4 receptor modulators
WO2008010238A2 (en) *	2006-07-21	2008-01-24	Lupin Limited	Antidiabetic azabicyclo [3. 1. 0] hexan compounds

2008
- 2008-06-13 FR FR0803297A patent/FR2932479A1/fr not_active Withdrawn
2009
- 2009-05-29 UY UY031857A patent/UY31857A1/es not_active Application Discontinuation
- 2009-05-29 SG SG200903642-7A patent/SG158015A1/en unknown
- 2009-06-01 PE PE2009000758A patent/PE20091961A1/es not_active Application Discontinuation
- 2009-06-03 GT GT200900150A patent/GT200900150A/es unknown
- 2009-06-03 MY MYPI20092264A patent/MY144748A/en unknown
- 2009-06-04 MX MX2009005891A patent/MX2009005891A/es not_active Application Discontinuation
- 2009-06-04 NZ NZ577438A patent/NZ577438A/en not_active IP Right Cessation
- 2009-06-05 ZA ZA200903939A patent/ZA200903939B/en unknown
- 2009-06-08 CL CL2009001377A patent/CL2009001377A1/es unknown
- 2009-06-08 CR CR10844A patent/CR10844A/es not_active Application Discontinuation
- 2009-06-08 AP AP2009004891A patent/AP2009004891A0/xx unknown
- 2009-06-09 EC EC2009009396A patent/ECSP099396A/es unknown
- 2009-06-09 NI NI200900114A patent/NI200900114A/es unknown
- 2009-06-10 SV SV2009003292A patent/SV2009003292A/es unknown
- 2009-06-10 AU AU2009202341A patent/AU2009202341A1/en not_active Abandoned
- 2009-06-11 EA EA200900692A patent/EA200900692A1/ru unknown
- 2009-06-11 WO PCT/FR2009/000696 patent/WO2009150331A1/fr not_active Ceased
- 2009-06-11 EP EP09290432A patent/EP2133333A1/fr not_active Withdrawn
- 2009-06-11 AR ARP090102108A patent/AR072101A1/es unknown
- 2009-06-12 MA MA31986A patent/MA31141B1/fr unknown
- 2009-06-12 CA CA002668527A patent/CA2668527A1/fr not_active Abandoned
- 2009-06-12 KR KR1020090052291A patent/KR20090129958A/ko not_active Ceased
- 2009-06-12 CO CO09061577A patent/CO6190096A1/es not_active Application Discontinuation
- 2009-06-12 JP JP2009140660A patent/JP2009298790A/ja not_active Withdrawn
- 2009-06-12 US US12/456,165 patent/US7906547B2/en not_active Expired - Fee Related
- 2009-06-12 TW TW098119836A patent/TW201000101A/zh unknown
- 2009-06-15 BR BRPI0902395-0A patent/BRPI0902395A2/pt not_active Application Discontinuation
- 2009-06-15 CN CNA2009101459752A patent/CN101602706A/zh active Pending

Also Published As

Publication number	Publication date
BRPI0902395A2 (pt)	2010-04-20
CR10844A (es)	2009-07-23
SG158015A1 (en)	2010-01-29
US7906547B2 (en)	2011-03-15
WO2009150331A1 (fr)	2009-12-17
MA31141B1 (fr)	2010-02-01
MY144748A (en)	2011-10-31
CO6190096A1 (es)	2010-08-19
NI200900114A (es)	2010-02-03
FR2932479A1 (fr)	2009-12-18
NZ577438A (en)	2010-09-30
EP2133333A1 (fr)	2009-12-16
SV2009003292A (es)	2010-02-01
EA200900692A1 (ru)	2009-12-30
AR072101A1 (es)	2010-08-04
CA2668527A1 (fr)	2009-12-13
UY31857A1 (es)	2009-08-31
CL2009001377A1 (es)	2010-05-28
TW201000101A (en)	2010-01-01
CN101602706A (zh)	2009-12-16
US20090312389A1 (en)	2009-12-17
JP2009298790A (ja)	2009-12-24
ZA200903939B (en)	2010-04-28
GT200900150A (es)	2011-08-25
MX2009005891A (es)	2010-02-17
KR20090129958A (ko)	2009-12-17
ECSP099396A (es)	2010-01-29
PE20091961A1 (es)	2010-01-23
AU2009202341A1 (en)	2010-01-07

Similar Documents

Publication	Publication Date	Title
ZA200704957B (en)	2008-08-27	Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
IL215016A0 (en)	2011-11-30	New benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions containing them
AP2014007774A0 (en)	2014-07-31	New pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
AP3024A (en)	2014-11-30	New Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
IL219602A (en)	2017-04-30	Tricyclic compounds containing pyrazole, a process for their preparation and their pharmaceutical compositions
SG151172A1 (en)	2009-04-30	1,2,4,5-tetrahydro-3h-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them
IL207183A0 (en)	2010-12-30	New dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
IL200128A0 (en)	2010-04-15	New tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them
IL217053A0 (en)	2012-02-29	Nanoparticulate candesarten cilexetil compositions, process for the preparation thereof and pharmaceutical compositions containing them
IL218525A (en)	2014-12-31	Compounds 2,1 - Dihydro - 2 - Oxoquinoline Receptor Legendants 5 - 4ht Process for Preparing, Containing and Using Medical Preparations
EP2393361A4 (en)	2012-10-17	PHARMACEUTICAL QUALITY PHTHALAZINEDIONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ZA200704955B (en)	2008-08-27	Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201000025B (en)	2011-04-28	New naphthalene compounds,a process for their preparation and pharmaceutical compositions containing them
AP2009004891A0 (en)	2009-06-30	New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them
IL206885A0 (en)	2010-12-30	New chromene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200704956B (en)	2008-08-27	Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201000024B (en)	2011-04-28	New naphthalene compounds,a process for their preparation and pharmaceutical compositions containing them
ZA201106353B (en)	2012-05-30	Dihydrobenzoxathiazepine compounds,a process for their preparation and pharmaceutical compositions containing them
AP2010005304A0 (en)	2010-06-30	New 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them
AP3344A (en)	2015-07-31	New dihydro-oxazolobenzodiazepinone compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201203943B (en)	2013-08-28	New azabicyclo[3.1.0]hex-2-yl compounds,a process for their preparation and pharmaceutical compositions containing them
IL206884A0 (en)	2010-12-30	New piperidine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200800833B (en)	2009-04-29	New 1H-indole-pyridinecarboxamide and 1H-indolepiperidinecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
AP2755A (en)	2013-09-30	New azabicyclo[3.2.0]hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200708215B (en)	2008-09-25	Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them